Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry
Link
https://www.nature.com/articles/s12276-018-0053-x.pdf
Reference39 articles.
1. Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42, 1050–1065 (2003).
2. Gross, J. L. et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28, 176–188 (2005).
3. Vilayur, E. & Harris, D. C. Emerging therapies for chronic kidney disease: what is their role? Nat. Rev. Nephrol. 5, 375–383 (2009).
4. Vallon, V., Muhlbauer, B. & Osswald, H. Adenosine and kidney function. Physiol. Rev. 86, 901–940 (2006).
5. Rabadi, M. M. & Lee, H. T. Adenosine receptors and renal ischaemia reperfusion injury. Acta Physiol. 213, 222–231 (2015).
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus;Journal of the Taiwan Institute of Chemical Engineers;2024-10
2. Structure–Activity Relationship of Truncated 4′-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity;ACS Medicinal Chemistry Letters;2024-08-22
3. PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms;Molecular Biology Reports;2024-02-15
4. Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01
5. Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR‐30a‐3p/TRIM16 axis;Journal of Diabetes Investigation;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3